Avicanna Inc
Research Avicanna Inc (AVCN) on Bullrun: market cap CAD 16.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVCN
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Market capCAD 16.35M
- Financial periodQ1 2026
- RevenueCAD 6.68M
- Net income-CAD 288.90K
- Free cash flow-CAD 969.35K
- Gross margin57.5%
Valuation Snapshot
latest market cap is CAD 16.35M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 25.48M | -CAD 2.84M | -CAD 1.44M | 53.1% | n/a | CAD 280.63K | CAD 0 | CAD 2.84M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 16.35M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Avicanna Inc's market cap?
Avicanna Inc's market capitalization is CAD 16.35M.
What does Avicanna Inc do?
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally.